021-51111890
购物车（）
sales@molnova.cn
Doripenem
CAS No. 148016-81-3
Doripenem ( —— )
产品货号. M22509 CAS No. 148016-81-3
Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥405 | 有现货 |
|
| 25MG | ￥689 | 有现货 |
|
| 50MG | ￥1037 | 有现货 |
|
| 100MG | ￥1555 | 有现货 |
|
| 200MG | ￥2325 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Doripenem
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
-
产品描述Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
-
同义词——
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体antibiotic
-
研究领域infection;Urinary system;Respiratory system
-
适应症Infection|Cross Infection|Bacterial Infections|Pneumonia, Ventilator-Associated|Intra-abdominal Infections|Urinary Tract Infections
化学信息
-
CAS Number148016-81-3
-
分子量420.5
-
分子式C15H24N4O6S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Wagenlehner, Florian, M, et al. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program[J]. Clinical Infectious Diseases, 2016.
产品手册
关联产品
-
Nevadensin
Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM. Nevadensin has a variety of pharmacological effects such as anti-mycobacterium tuberculosis activities, antitussive, anti-inflammatory and anti-hypertensive.
-
Phanquinone
Phanquinone is active against a wide range of Gram-positive and Gram-negative organisms.
-
Durlobactam
Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
